Basic Information
Decoy Biosystems is a biotechnology company dedicated to cancer immunotherapy for patients with unresectable or metastatic solid tumors and lymphomas, which account for approximately 90% of all cancer deaths. Currently, the company has developed a novel cancer immunotherapy based on multi-Toll-like receptor (TLR) agonists.
Decoy Biosystems, Inc.
SanDiego,California,United States of America
unclear
August 14, 2013
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios